Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Carlos M. De Castro III, MD

Professor of Medicine
Duke Cancer Center
Durham, North Carolina

Disclosures

Carlos M. De Castro III, MD, has the following relevant financial relationships:
Consultant or advisor for: Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; BioCryst Pharmaceuticals, Inc.; Novartis Pharmaceuticals; Regeneron Pharmaceuticals, Inc.; Omeros Corporation
Speaker or member of speakers bureau for: Omeros Corporation
Research funding from: Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; Novartis Pharmaceuticals
Other: DMSB Regeneron Pharmaceuticals, Inc.

Srikanth Nagalla, MD, MS

Chief of Benign Hematology
Miami Cancer Institute
Clinical Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida

Disclosures

Srikanth Nagalla, MD, MS, has the following relevant financial relationships:
Consultant or advisor for: Agios Pharmaceuticals; Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; Pharmacosmos; Rigel; Sanofi; Swedish Orphan Biovitrum
Speaker or member of speakers bureau for: Agios Pharmaceuticals; Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; Rigel; Sanofi; Swedish Orphan Biovitrum

Spero R. Cataland, MD

Professor of Internal Medicine
Division of Hematology
Section Head
Benign Hematology
Ohio State University
Columbus, Ohio

Disclosures

Spero R. Cataland, MD, has the following relevant financial relationships:
Consultant or advisor for: Sanofi; Takeda

Editor

Deborah Middleton, MS

Senior Medical Education Director, WebMD Global, LLC

Disclosures

Deborah Middleton, MS, has no relevant financial relationships.

Global Genes Course Director

Shruti Mitkus, PhD

Director
Genetic Education and Navigation
Global Genes

Disclosures

Shruti Mitkus, PhD, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

Rare Tidbits: Underscoring Key Topics for the Care of Patients With Rare Hematologic Disorders

Authors: Carlos M. De Castro III, MD; Srikanth Nagalla, MD, MS; Spero R. Cataland, MD
CME Released: 11/2/2023
Valid for credit through: 11/2/2024, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for hematologists/oncologists, primary care physicians, pediatricians, emergency medicine physicians, and other healthcare professionals involved in the care of patients with rare hematologic disorders.

The goal of this activity is for learners to be better able to care for patients with rare hematologic disorders.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Clinical trial data evaluating treatment strategies for patients with rare hematologic disorders
- Mechanisms of action of treatments used for rare hematologic disorders
- Identification of potential adverse events associated with treatment strategies for rare hematologic disorders
Have greater competence related to
- Diagnosing patients with rare hematologic disorders
- Creating customized treatment plans for patients with rare hematologic disorders

Disclosures

Faculty

Carlos M. De Castro III, MD

Professor of Medicine
Duke Cancer Center
Durham, North Carolina

Disclosures

Carlos M. De Castro III, MD, has the following relevant financial relationships:
Consultant or advisor for: Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; BioCryst Pharmaceuticals, Inc.; Novartis Pharmaceuticals; Regeneron Pharmaceuticals, Inc.; Omeros Corporation
Speaker or member of speakers bureau for: Omeros Corporation
Research funding from: Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; Novartis Pharmaceuticals
Other: DMSB Regeneron Pharmaceuticals, Inc.

Srikanth Nagalla, MD, MS

Chief of Benign Hematology
Miami Cancer Institute
Clinical Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida

Disclosures

Srikanth Nagalla, MD, MS, has the following relevant financial relationships:
Consultant or advisor for: Agios Pharmaceuticals; Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; Pharmacosmos; Rigel; Sanofi; Swedish Orphan Biovitrum
Speaker or member of speakers bureau for: Agios Pharmaceuticals; Alexion Pharmaceuticals, Inc.; Apellis Pharmaceuticals; Rigel; Sanofi; Swedish Orphan Biovitrum

Spero R. Cataland, MD

Professor of Internal Medicine
Division of Hematology
Section Head
Benign Hematology
Ohio State University
Columbus, Ohio

Disclosures

Spero R. Cataland, MD, has the following relevant financial relationships:
Consultant or advisor for: Sanofi; Takeda

Editor

Deborah Middleton, MS

Senior Medical Education Director, WebMD Global, LLC

Disclosures

Deborah Middleton, MS, has no relevant financial relationships.

Global Genes Course Director

Shruti Mitkus, PhD

Director
Genetic Education and Navigation
Global Genes

Disclosures

Shruti Mitkus, PhD, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

Developed through a partnership between Medscape and Global Genes.

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Oncology

CME

Rare Tidbits: Underscoring Key Topics for the Care of Patients With Rare Hematologic Disorders

Authors: Carlos M. De Castro III, MD; Srikanth Nagalla, MD, MS; Spero R. Cataland, MDFaculty and Disclosures

CME Released: 11/2/2023

Valid for credit through: 11/2/2024, 11:59 PM EST

processing....

Select Any Chapter to Begin

Page 1 of 25

Transplant-Associated Thrombotic Microangiopathy - Pre-Assessment

Earn Credit CME Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Carlos M. De Castro III, MD

Srikanth Nagalla, MD, MS

Spero R. Cataland, MD

Editor

Deborah Middleton, MS

Global Genes Course Director

Shruti Mitkus, PhD

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME

Rare Tidbits: Underscoring Key Topics for the Care of Patients With Rare Hematologic Disorders

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Carlos M. De Castro III, MD

Srikanth Nagalla, MD, MS

Spero R. Cataland, MD

Editor

Deborah Middleton, MS

Global Genes Course Director

Shruti Mitkus, PhD

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Rare Tidbits: Underscoring Key Topics for the Care of Patients With Rare Hematologic Disorders

Select Any Chapter to Begin